{"id":4802,"date":"2021-08-11T11:45:49","date_gmt":"2021-08-11T08:45:49","guid":{"rendered":"https:\/\/www.klimik.org.tr\/koronavirus\/?p=4802"},"modified":"2021-08-21T12:29:19","modified_gmt":"2021-08-21T09:29:19","slug":"dsonun-solidarity-klinik-arastirmasi-uc-yeni-aday-ilacla-yeni-bir-asamaya-giriyor","status":"publish","type":"post","link":"https:\/\/www.klimik.org.tr\/koronavirus\/dsonun-solidarity-klinik-arastirmasi-uc-yeni-aday-ilacla-yeni-bir-asamaya-giriyor\/","title":{"rendered":"DS\u00d6&#8217;n\u00fcn Solidarity Klinik Ara\u015ft\u0131rmas\u0131, \u00dc\u00e7 Yeni Aday \u0130la\u00e7la Yeni Bir A\u015famaya Giriyor"},"content":{"rendered":"<p><img decoding=\"async\" loading=\"lazy\" class=\"size-full wp-image-18329 alignleft\" src=\"https:\/\/www.klimik.org.tr\/wp-content\/uploads\/2013\/07\/who-logo-k\u00fc\u00e7\u00fck.jpg\" alt=\"\" width=\"100\" height=\"32\" \/><strong>D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc (DS\u00d6), Solidarity (Dayan\u0131\u015fma) denemesinde bir sonraki a\u015famay\u0131 duyurdu. Solidarity PLUS kapsam\u0131nda, hastanede yatan COVID-19 hastalar\u0131nda \u00fc\u00e7 yeni ilac\u0131 test etmek i\u00e7in, hastaneye yat\u0131r\u0131lan hastalar kaydedilecek. Umut vaat eden ila\u00e7lar i\u00e7in Solidarity PLUS denemesi 52 \u00fclkede uygulanacak ve COVID-19 Ar-Ge i\u00e7in benzeri g\u00f6r\u00fclmemi\u015f bir k\u00fcresel i\u015fbirli\u011fi olacak.<\/strong><\/p>\n<p>Bu ila\u00e7lar &#8211; artesunat, imatinib ve infliximab &#8211; hastanede yatan COVID-19 hastalar\u0131nda \u00f6l\u00fcm riskini azaltma potansiyelleri nedeniyle ba\u011f\u0131ms\u0131z bir uzman paneli taraf\u0131ndan se\u00e7ilmi\u015ftir. \u0130la\u00e7lar halen ba\u015fka endikasyonlar i\u00e7in kullan\u0131lmaktad\u0131r; artesunat \u015fiddetli s\u0131tma i\u00e7in, imatinib belirli kanserler i\u00e7in, infliksimab ise Crohn Hastal\u0131\u011f\u0131 ve romatoid artrit gibi ba\u011f\u0131\u015f\u0131kl\u0131k sistemi hastal\u0131klar\u0131 i\u00e7in kullan\u0131lmaktad\u0131r.<\/p>\n<p>Bu ila\u00e7lar, \u00fcreticileri taraf\u0131ndan ara\u015ft\u0131rma i\u00e7in ba\u011f\u0131\u015flanm\u0131\u015ft\u0131r.<\/p>\n<p><a href=\"https:\/\/www.who.int\/news\/item\/11-08-2021-who-s-solidarity-clinical-trial-enters-a-new-phase-with-three-new-candidate-drugs\"><strong>Haber \u0130\u00e7in T\u0131klay\u0131n\u0131z\u00a0<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc (DS\u00d6), Solidarity (Dayan\u0131\u015fma) denemesinde bir sonraki a\u015famay\u0131 duyurdu. Solidarity PLUS kapsam\u0131nda, hastanede yatan COVID-19 hastalar\u0131nda \u00fc\u00e7 yeni ilac\u0131 test etmek i\u00e7in, hastaneye yat\u0131r\u0131lan hastalar kaydedilecek. Umut vaat eden ila\u00e7lar i\u00e7in Solidarity PLUS denemesi 52 \u00fclkede uygulanacak ve COVID-19 Ar-Ge i\u00e7in benzeri g\u00f6r\u00fclmemi\u015f bir k\u00fcresel i\u015fbirli\u011fi olacak. Bu ila\u00e7lar &#8211; artesunat, imatinib ve infliximab &#8211; hastanede yatan COVID-19 hastalar\u0131nda \u00f6l\u00fcm riskini azaltma potansiyelleri nedeniyle ba\u011f\u0131ms\u0131z bir uzman paneli taraf\u0131ndan se\u00e7ilmi\u015ftir. \u0130la\u00e7lar halen ba\u015fka endikasyonlar i\u00e7in kullan\u0131lmaktad\u0131r; artesunat \u015fiddetli s\u0131tma i\u00e7in, imatinib belirli kanserler i\u00e7in, infliksimab ise Crohn Hastal\u0131\u011f\u0131 ve romatoid artrit gibi ba\u011f\u0131\u015f\u0131kl\u0131k sistemi hastal\u0131klar\u0131 i\u00e7in kullan\u0131lmaktad\u0131r. Bu [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":4862,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/4802"}],"collection":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/comments?post=4802"}],"version-history":[{"count":2,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/4802\/revisions"}],"predecessor-version":[{"id":4804,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/4802\/revisions\/4804"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media\/4862"}],"wp:attachment":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media?parent=4802"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/categories?post=4802"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/tags?post=4802"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}